Latest News

  • INNOVATION

    14 Nov 2025

    Can Tiny Injections Replace Big Infusions
  • TECHNOLOGY

    12 Nov 2025

    AI Redesigns How America Makes Its Medicines
  • PARTNERSHIPS

    11 Nov 2025

    Allies in Innovation: The Rise of Drug Delivery Partnerships
  • RESEARCH

    7 Nov 2025

    Nanoform and Takeda Bet on Miniature Science

The Next Big Breakthrough in Biologics Starts at Home

The Next Big Breakthrough in Biologics Starts at Home

INNOVATION

5 Nov 2025

Halozyme’s Elektrofi buy brings next-gen innovation to biologic drug delivery

Exterior view of Halozyme building featuring logo above main entrance.

INNOVATION

14 Nov 2025

Can Tiny Injections Replace Big Infusions

Halozyme’s move to buy Elektrofi puts high dose injectables at the center of a push for simpler biologic care

Robotic arm in a bright automated laboratory used for advanced pharmaceutical or biotech processes.

TECHNOLOGY

12 Nov 2025

AI Redesigns How America Makes Its Medicines

Duke scientists use AI to cut a carcinogenic additive by 75%, proving safer drug design is within reach

Allies in Innovation: The Rise of Drug Delivery Partnerships

PARTNERSHIPS

11 Nov 2025

Allies in Innovation: The Rise of Drug Delivery Partnerships

AmacaThera-Pacira and MannKind-scPharmaceuticals deals mark a new model for biotech collaboration

Nanoform and Takeda Bet on Miniature Science

RESEARCH

7 Nov 2025

Nanoform and Takeda Bet on Miniature Science

Nanoform and Takeda test nanoparticle delivery for biologics, with early in-vivo results due in 2025

The Next Big Breakthrough in Biologics Starts at Home

INNOVATION

5 Nov 2025

The Next Big Breakthrough in Biologics Starts at Home

Halozyme’s Elektrofi buy brings next-gen innovation to biologic drug delivery

Pill Power: Lexaria’s $4M Shot at Ending Injections

INVESTMENT

3 Nov 2025

Pill Power: Lexaria’s $4M Shot at Ending Injections

Lexaria secures $4M to turn injectable drugs into pills with its DehydraTECH delivery platform

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.